Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000961939 | SCV001108997 | likely benign | not provided | 2018-04-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029899 | SCV002675828 | likely benign | not specified | 2022-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000961939 | SCV004125949 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | OBSCN: BP4, BP7 |
Prevention |
RCV003943112 | SCV004766198 | likely benign | OBSCN-related disorder | 2019-11-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |